Role of FAT/CD36 in fatty acid sensing, energy, and glucose homeostasis regulation in DIO and DR rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 308, Issue 3, 2015, Pages R188-R198

  Le Foll, Christelle ^a   Dunn Meynell, Ambrose A ^b   Levin, Barry E ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CD36; Fatty acid; Hypothalamus; Neuronal sensing; Obesity

Indexed keywords

CD36 ANTIGEN; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; SHORT HAIRPIN RNA; GLUCOSE BLOOD LEVEL; 3 HYDROXYBUTYRIC ACID; AGOUTI RELATED PROTEIN; CALCIUM ION; CARNITINE PALMITOYLTRANSFERASE; CYCLOPHILIN; FATTY ACID SYNTHASE; FATTY ACID TRANSPORTER; GLUCOKINASE; HORMONE SENSITIVE LIPASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MALONYL COENZYME A DECARBOXYLASE; NEUROPEPTIDE Y; OLEIC ACID; PARVOVIRUS VECTOR; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENERGY; ENERGY BALANCE; GLUCOSE HOMEOSTASIS; INSULIN RESISTANCE; LIPID STORAGE; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; REGULATORY MECHANISM; WEIGHT; WEIGHT GAIN; ZONA INCERTA; ADIPOSE TISSUE; ANIMAL; ANIMAL FOOD; BODY WEIGHT; CALORIC INTAKE; DISEASE MODEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; OBESITY; PHYSIOLOGY; ANIMAL TISSUE; ARCUATE NUCLEUS; AREA UNDER THE CURVE; BRAIN NERVE CELL; CALCIUM SIGNALING; DIET INDUCED OBESITY; FAT MASS; FOOD INTAKE; GENE EXPRESSION; HORMONE BLOOD LEVEL; HOUSEKEEPING GENE; HYPERPHAGIA; HYPOTHALAMUS; INSULIN SENSITIVITY; LIPID DIET; LIVER; ORAL GLUCOSE TOLERANCE TEST; PERINATAL PERIOD; PROTEIN FUNCTION; STUNTING; SUBCUTANEOUS FAT; THALAMUS VENTRAL NUCLEUS;

ADIPOSE TISSUE; ANIMAL FEED; ANIMALS; ANTIGENS, CD36; BLOOD GLUCOSE; BODY WEIGHT; DISEASE MODELS, ANIMAL; ENERGY INTAKE; FATTY ACIDS; HOMEOSTASIS; INSULIN; LEPTIN; MALE; OBESITY; RATS;

EID: 84923125426     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00367.2014     Document Type: Article

References (62)

1. Al-Almaie SM. Prevalence of obesity and overweight among Saudi adolescents in Eastern Saudi Arabia. Saudi Med J 26: 607–611, 2005.
2. Anand BK, Chhina GS, Sharma KN, Dua S, Singh B. Activity of single neurons in the hypothalamus feeding centers: effect of glucose. Am J Physiol 207: 1146–1154, 1964.
3. Andersen LF, Lillegaard IT, Overby N, Lytle L, Klepp KI, Johansson L. Overweight and obesity among Norwegian schoolchildren: changes from 1993 to 2000. Scand J Public Health 33: 99–106, 2005.
4. Balthasar N, Coppari R, McMinn J, Liu SM, Lee CE, Tang V, Kenny CD, McGovern RA, Chua SC Jr, Elmquist JK, Lowell BB. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42: 983–991, 2004.
5. Barker DJ. The developmental origins of adult disease. Eur J Epidemiol 18: 733–736, 2003.
6. Baskin ML, Ard J, Franklin F, Allison DB. Prevalence of obesity in the United States. Obes Rev 6: 5–7, 2005.
7. Bouret SG. Organizational actions of metabolic hormones. Front Neuroendocrinol 34: 18–26, 2013.
8. Briggs D, Lemus M, Kua E, Andrews Z. Diet-induced obesity attenuates fasting-induced hyperphagia. J Neuroendocrinol 23: 620–626, 2011.
9. Chanoine JP, De Waele K, Walia P. Ghrelin and the growth hormone secretagogue receptor in growth and development. Int J Obes 33 Suppl 1: S48–S52, 2009.
10. Clement L, Cruciani-Guglielmacci C, Magnan C, Vincent M, Douared L, Orosco M, Assimacopoulos-Jeannet F, Penicaud L, Ktorza A. Intracerebroventricular infusion of a triglyceride emulsion leads to both altered insulin secretion and hepatic glucose production in rats. Pflügers Arch 445: 375–380, 2002.
11. Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE. Glucokinase is the likely mediator of glucosensing in both glucose excited and glucose inhibited central neurons. Diabetes 51: 2056–2065, 2002.
12. Dunn-Meynell AA, Sanders NM, Compton D, Becker TC, Eiki J, Zhang BB, Levin BE. Relationship among brain and blood glucose levels and spontaneous and glucoprivic feeding. J Neurosci 29: 7015–7022, 2009.
13. Ferre P, Foufelle F. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res 68: 72–82, 2007.
14. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among us. Adults Diabetes Care 27: 2444–2449, 2004.
15. Glatz JF, Luiken JJ, Bonen A. Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake. J Mol Neurosci 16: 123–132; discussion 151–127, 2001.
16. Gorski J, Levin BE. Effects of cross fostering on body weight, adiposity and insulin sensitivity in selectively bred obesity-prone and resistant rats. Obes Res 12: A103, 2004.
17. Imagawa A, Hanafusa T, Itoh N, Miyagawa J, Nakajima H, Namba M, Kuwajima M, Tamura S, Kawata S, Matsuzawa Y, Harlan DM. Islet-infiltrating T lymphocytes in insulin-dependent diabetic patients express CD80 (B7–1) and CD86 (B7–2). J Autoimmun 9: 391–396, 1996.
18. Imagawa A, Itoh N, Hanafusa T, Katsura H, Yamaguchi A, Takeda A, Iwahashi H, Nakajima H, Miyagawa J, Namba M, Kuwajima M, Matsuzawa Y. High prevalence of antibodies to glutamic acid decarboxylase compared with islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus. Res Commun Mol Pathol Pharmacol 92: 43–52, 1996.
19. Jeha GS, Heptulla RA. Newer therapeutic options for children with diabetes mellitus: theoretical and practical considerations. Pediatr Diabetes 7: 122–138, 2006.
20. Kang L, Dunn-Meynell AA, Routh VH, Gaspers LD, Nagata Y, Nishimura T, Eiki J, Zhang BB, Levin BE. Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing. Diabetes 55: 412–420, 2006.
21. Kang L, Dunn-Meynell AA, Routh VH, Liu X, Levin BE. Knockdown of GK mRNA with GK RNA interference (RNAi) blocks ventromedial hypothalamic (VMH) neuronal glucosensing. Diabetes 53: A43, 2004.
22. Kang L, Routh VH, Kuzhikandathil EV, Gaspers L, Levin BE. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 53: 549–559, 2004.
23. Keinan-Boker L, Noyman N, Chinich A, Green MS, Nitzan-Kaluski D. Overweight and obesity prevalence in Israel: findings of the first national health and nutrition survey (MABAT). Isr Med Assoc J 7: 219–223, 2005.
24. Koopman R, Schaart G, Hesselink MK. Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol 116: 63–68, 2001.
25. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40: 1397–1403, 1991.
26. Lam TK, Pocai A, Gutierrez-Juarez R, Obici S, Bryan J, Aguilar- Bryan L, Schwartz GJ, Rossetti L. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med 11: 320–327, 2005.
27. Le Foll C, Dunn-Meynell A, Musatov S, Magnan C, Levin BE. FAT/CD36: a major regulator of neuronal fatty acid sensing and energy homeostasis in rats and mice. Diabetes 62: 2709–2716, 2013.
28. Le Foll C, Irani BG, Magnan C, Dunn-Meynell AA, Levin BE. Characteristics and mechanisms of hypothalamic neuronal fatty acid sensing. Am J Physiol Regul Integr Comp Physiol 297: R655–R664, 2009.
29. Le Foll C, Irani BG, Magnan C, Dunn-Meynell AA, Levin BE. Effects of maternal genotype and diet on offspring glucose and fatty acid sensing ventromedial hypothalamic nucleus neurons. Am J Physiol Regul Integr Comp Physiol 297: R1351–R1357, 2009.
30. Levin BE. Metabolic sensors: viewing glucosensing neurons from a broader perspective. Physiol Behav 76: 397–401, 2002.
31. Levin BE, Becker TC, Eiki J, Zhang BB, Dunn-Meynell AA. Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia. Diabetes 57: 1371–1379, 2008.
32. Levin BE, Dunn-Meynell AA. Differential effects of exercise on body weight gain and adiposity in obesity-prone and -resistant rats. Int J Obes 30: 722–727, 2006.
33. Levin BE, Dunn-Meynell AA. Reduced central leptin sensitivity in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 283: R941–R948, 2002.
34. Levin BE, Dunn-Meynell AA, Balkan B, Keesey RE. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 273: R725–R730, 1997.
35. Levin BE, Dunn-Meynell AA, Ricci MR, Cummings DE. Abnormalities of leptin and ghrelin regulation in obesity-prone juvenile rats. Am J Physiol Endocrinol Metab 285: E949–E957, 2003.
36. Levin BE, Govek EK, Dunn-Meynell AA. Reduced glucose-induced neuronal activation in the hypothalamus of diet-induced obese rats. Brain Res 808: 317–319, 1998.
37. Levin BE, Keesey RE. Defense of differing body weight set-points in diet-induced obese and resistant rats. Am J Physiol Regul Integr Comp Physiol 274: R412–R419, 1998.
38. Levin BE, Magnan C, Migrenne S, Chua SC Jr, Dunn-Meynell AA. The F-DIO obesity-prone rat is insulin resistant prior to obesity onset. Am J Physiol Regul Integr Comp Physiol 289: R704–R711, 2005.
39. Levin BE, Strack AM. Diet-induced obesity in animal models and what they tell us about human obesity. In: Neurobiology of Obesity, edited by Harvey J and Withers DJ. Cambridge, MA: Cambridge University Press, 2008, p. 164–195.
40. Little TJ, Isaacs NJ, Young RL, Ott R, Nguyen NQ, Rayner CK, Horowitz M, Feinle-Bisset C. Characterization of duodenal expression and localization of fatty acid-sensing receptors in humans: relationships with body mass index. Am J Physiol Gastrointest Liver Physiol 307: G958–G967, 2014.
41. Martin C, Chevrot M, Poirier H, Passilly-Degrace P, Niot I, Besnard P. CD36 as a lipid sensor. Physiol Behav 105: 36–42, 2011.
42. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462–1470, 1999.
43. McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 96: E1756–E1760, 2011.
44. Migrenne S, Cruciani-Guglielmacci C, Kang L, Wang R, Rouch C, Lefevre AL, Ktorza A, Routh VH, Levin BE, Magnan C. Fatty acid signaling in the hypothalamus and the neural control of insulin secretion. Diabetes. 55 Suppl 2: S139–S144, 2006.
45. Nguyen NL, Randall J, Banfield BW, Bartness TJ. Central sympathetic innervations to visceral and subcutaneous white adipose tissue. Am J Physiol Regul Integr Comp Physiol 306: R375–R386, 2014.
46. Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51: 271–275, 2002.
47. Oomura Y, Kimura K, Ooyama H, Maeo T, Iki M, Kuniyoshi N. Reciprocal activities of the ventromedial and lateral hypothalamic area of cats. Science 143: 484–485, 1964.
48. Oomura Y, Nakamura T, Sugimori M, Yamada Y. Effect of free fatty acid on the rat lateral hypothalamic neurons. Physiol Behav 14: 483–486, 1975.
49. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116: 760–768, 2006.
50. Pocai A, Lam TK, Obici S, Gutierrez-Juarez R, Muse ED, Arduini A, Rossetti L. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest 116: 1081–1091, 2006.
51. Ricci MR, Levin BE. Ontogeny of diet-induced obesity in selectivelybred Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 285: R610–R618, 2003.
52. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279: 32,345–32,353, 2004.
53. Simpson JL. Genetics of diabetes mellitus (DM) and anomalies in offspring of diabetic mothers. Semin Perinatol 2: 383–394, 1978.
54. Song Z, Levin BE, McArdle JJ, Bakhos N, Routh VH. Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus (VMN). Diabetes 50: 2673–2681, 2001.
55. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Engl J Med 322: 1483–1487, 1990.
56. Tessari P, Coracina A, Cosma A, Tiengo A. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 19: 291–302, 2009.
57. van de Wall E, Leshan R, Xu AW, Balthasar N, Coppari R, Liu SM, Jo YH, MacKenzie RG, Allison DB, Dun NJ, Elmquist J, Lowell BB, Barsh GS, de Luca C, Myers MG Jr, Schwartz GJ, Chua SC, Jr. Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology 149: 1773–1785, 2008.
58. Van Den Top M, Lee K, Whyment AD, Blanks AM, Spanswick D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat Neurosci 7: 493–494, 2004.
59. Wang R, Liu X, Hentges ST, Dunn-Meynell AA, Levin BE, Wang W, Routh VH. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53: 1959–1965, 2004.
60. Wang Y. Cross-national comparison of childhood obesity: the epidemic and the relationship between obesity and socioeconomic status. Int J Epidemiol 30: 1129–1136, 2001.
61. Weiss PA, Scholz HS, Haas J, Tamussino KF, Seissler J, Borkenstein MH. Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of diabetes and precursors. Diabetes Care 23: 905–911, 2000.
62. Willesen MG, Kristensen P, Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70: 306–316, 1999.